(tuberculosis OR MTB OR MTB/RIF OR “tubercle bacillus” OR Tuberculosis [MeSH] OR Mycobacterium OR “M. africanum” OR “M. bovis” OR “M. microti” OR “M. canettii” OR “M. caprae” OR “M. pinnipedii” OR “M. mungi”) AND (“rpoB protein, Mycobacterium tuberculosis” [Supplementary Concept] OR rpoB OR resistant OR resistance OR “multidrug resistant” OR MDR OR “Drug resistance, Bacterial” [MeSH])
Intervention
N/A
Comparator (if applicable)
(Rifampin [MeSH] OR rifampicin OR benemycin OR rimactan OR tubacin OR rifadin OR rimactane OR isoniazid)
Outcomes (if applicable)
(infectious OR contagious OR contacts OR delay OR “excess morbidity” OR “excess mortality” OR public health OR outbreak)
Limits
1990 – June 2014; NOT (Other Animals NOT Humans)
MeSH = Medical Subject Heading, based on a Medline/PubMed platform; N/A = not applicable
Table Search terms used for impact of early versus delayed treatment for TB
